Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of integrin alpha(v)beta3 in vascular biology.

× No keyword cloud information.

26 in total

Review 1. Antithrombotic therapy in the cardiac catheterization laboratory: focus on antiplatelet agents.

Authors: M I Furman; A L Frelinger III; A D Michelson
Journal: Curr Cardiol Rep Date: 2000-09 Impact factor: 2.931

Review 2. Antiangiogenic therapies for glioblastoma.

Authors: Isabel Arrillaga-Romany; Andrew D Norden
Journal: CNS Oncol Date: 2014

3. Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug.

Authors: Yuan Liu; Krishna Mohan Bajjuri; Cheng Liu; Subhash C Sinha
Journal: Mol Pharm Date: 2011-11-22 Impact factor: 4.939

4. A role for activated endothelial cells in red blood cell clearance: implications for vasopathology.

Authors: Marcel H A M Fens; Richard van Wijk; Grietje Andringa; Karlijn L van Rooijen; Hilde M Dijstelbloem; Jan T Rasmussen; Karen M K de Vooght; Raymond M Schiffelers; Carlo A J M Gaillard; Wouter W van Solinge
Journal: Haematologica Date: 2011-11-18 Impact factor: 9.941

5. Anti-inflammatory effects of alphav integrin antagonism in acute kidney allograft rejection.

Authors: Jens Bedke; Eva Kiss; Carl-Ludwig Behnes; Zoran V Popovic; Markus Heuser; Tomislav Stojanovic; Tjeerd Sijmonsma; Peter Huber; Sophie Domhan; Stefan Muschal; Amir Abdollahi; Norbert Gretz; Hermann-Josef Gröne
Journal: Am J Pathol Date: 2007-08-16 Impact factor: 4.307

6. Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner.

Authors: Jun Saegusa; Nobuaki Akakura; Chun-Yi Wu; Case Hoogland; Zi Ma; Kit S Lam; Fu-Tong Liu; Yoko K Takada; Yoshikazu Takada
Journal: J Biol Chem Date: 2008-07-17 Impact factor: 5.157

Review 7. The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors: Barry S Coller; Sanford J Shattil
Journal: Blood Date: 2008-10-15 Impact factor: 22.113

Review 8. Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.

Authors: Giuseppe De Luca; Stefano Savonitto; Arnoud W J van't Hof; Harry Suryapranata
Journal: Drugs Date: 2015-07 Impact factor: 9.546

Review 9. Integrin αIIbβ3: from discovery to efficacious therapeutic target.

Authors: Kamila Bledzka; Susan S Smyth; Edward F Plow
Journal: Circ Res Date: 2013-04-12 Impact factor: 17.367

10. QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model.

Authors: Jessica Kalra; Corinna Warburton; Karen Fang; Lincoln Edwards; Tim Daynard; Dawn Waterhouse; Wieslawa Dragowska; Brent W Sutherland; Shoukat Dedhar; Karen Gelmon; Marcel Bally
Journal: Breast Cancer Res Date: 2009-05-01 Impact factor: 6.466